Human uterine NK cells have a similar repertoire of killer inhibitory and activatory receptors to those found in blood, as demonstrated by RT-PCR and sequencing

Molecular Immunology

Volumn 34, Issue 5, 1997, Pages 419-430

  Hiby, Susan E ^a   King, Ashley ^a   Sharkey, Andrew M ^a   Loke, Yung Wai ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Decidua; HLA class I; KIR; NK cells

Indexed keywords

CELL RECEPTOR; HLA ANTIGEN CLASS 1;

ARTICLE; CONTROLLED STUDY; DECIDUA; FEMALE; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NATURAL KILLER CELL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS;

ANTIGENS, CD56; DNA, COMPLEMENTARY; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; RNA-DIRECTED DNA POLYMERASE; SEQUENCE ANALYSIS, DNA; UTERUS;

EID: 0030820118     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(97)00032-1     Document Type: Article

References (62)

1. Biassoni R., Cantoni C., Falco M., Verdiani S., Bottino C., Vitale M., Conte R., Poggi A., Moretta A. and Moretta L. (1996) The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. exp. Med. 183, 645-650.
2. Bottino C., Sivori S., Vitale M., Cantoni C., Falco M., Pende D., Morelli L., Augugliaro R., Semenzato G., Biassoni R., Moretta L. and Moretta A. (1991) A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur. J. Immun. 26, 1816-1824.
3. Bulmer J. N., Morrison L., Longfellow M., Ritson A. and Pace D. (1991) Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Human Reprod. 6, 791-798.
4. Burshtyn D. N., Scharenberg A. M., Wagtmann N., Rajagopalan S., Berrada K., Yi T., Kinet J.-P. and Long E. O. (1996) Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4, 77-80.
5. Campbell K. S., Dessing M., López-Botet M., Cella M. and Colonna M. (1996) Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. exp. Med. 184, 93-100.
6. Chomczynski P. and Sacchi E. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162, 156-159.
7. Chumbley G., King A., Gardner L., Howlett S., Holmes N. and Loke Y. W. (1994a) Generation of an antibody to HLA-G in transgenic mice and demonstration of the tissue reactivity of this antibody. J. reprod. Immun. 27, 173-186.
8. Chumbley G., King A., Robertson K., Holmes N. and Loke Y. W. (1994b) Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell. Immun. 155, 312-322.
9. Colonna M. and Samaridis J. (1995) Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268, 405-408.
10. Colonna M., Spies T., Strominger J. L., Ciccone E., Moretta A., Moretta L., Pende D. and Viale O. (1992) Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc. natn. Acad. Sci. U.S.A. 89, 7983-7985.
11. Colonna M., Borsellino G., Falco M., Ferrara G. B. and Strominger J. L. (1993) HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. natn. Acad. Sci. U.S.A. 90, 12000-12004.
12. D'Andrea A., Chang C., Franz-Bacon K., McClanahan T., Philips J. J. and Lanier L. L. (1995) Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J. Immun. 155, 2306-2310.
13. - decidual and peripheral blood leukocytes. J. Immun. 152, 4255-4261.
14. Döhring C. and Colonna M. (1996) Human natural killer cell inhibitory receptors bind to HLA class I molecules. Eur. J. Immun. 26, 365-369.
15. Döhring C., Samaridis J. and Colonna M. (1996a) Alternatively spliced forms of human killer inhibitory receptors. Immunogenetics 44, 227-230.
16. Döhring C., Scheidegger D., Samaridis J., Cella M. and Colonna M. (1996b) A human killer inhibitory receptor specific for HLA-A. J. Immun. 156, 3098-3101.
17. Ellis S. A., Palmer M. S. and McMichael A. J. (1990) Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J. Immun. 144, 731-735.
18. Ellis S. A., Strachan T., Palmer M. S. and McMichael A. J. (1989) Complete nucleotide sequence of a unique HLA class I C locus product expressed on the human choriocarcinoma cell line BeWo. J. Immun. 142, 3281-3285.
19. Ferrini S., Cambiaggi A., Meazza R., Sforzini S., Marciano S., Mingari M. C. and Moretta L. (1994) T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immun. 24, 2294-2298.
20. Ferry B. L., Starkey P. M., Sargent I. L., Watt G. M.O., Jackson M. and Redman C. W.G. (1990) Cell populations in the human early pregnancy decidua: natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes. Immunology 70, 446-452.
21. Fry A. M., Lanier L. L. and Weiss A. (1996) Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J. exp. Med. 184, 295-300.
22. Gumperz J. E. and Parham P. (1995) The enigma of the natural killer cell. Nature 378, 245-248.
23. Gumperz J. E., Valiante N. M., Parham P., Lanier L. L. and Tyan D. (1996) Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotypes. J. exp. Med. 183, 1817-1827.
24. Jokhi P. P., King A. and Loke Y. W. (1994a) Production of GM-CSF by human trophoblast cells and by decidual large granular lymphocytes. Hum. Reprod. 9, 1660-1669.
25. Jokhi P., King A. and Loke Y. W. (1994b) Reciprocal expression of epidermal growth factor receptor (EGF-R) and c-erbB2 by non-invasive and invasive human trophoblast populations. Cytokine 6, 433-442.
26. Jokhi P. P., King A., Sharkey A. M., Smith S. K. and Loke Y. W. ( 1994c) Screening for cytokine mRNAs in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction (RT-PCR). J. Immun. 153, 4427-4435.
27. Jokhi P. P., King A., Boocock C. and Loke Y. W. (1995) Secretion of colony stimulating factor-1 (CSF-1) by human first trimester placental and decidual cell populations and the effect of this cytokine on trophoblast thymidine uptake in vitro. Mol. Hum. Reprod. 10, 2800-2807.
28. King A. and Loke Y. W. (1991) On the nature and function of human uterine granular lymphocytes. Immun. Today 12, 432-435.
29. King A. and Loke Y. W. (1994) Unexplained fetal growth retardation: what is the cause? Arch. Dis. Child. 70, 225-227.
30. King A., Wellings V., Gardner L. and Loke Y. W. (1989a) Immunocytochemical characterisation of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Human Immun. 24, 195-205.
31. King A., Birkby C. and Loke Y. W. (1989b) Early human decidual cells exhibit NK activity against K562 cell line but not against first trimester trophoblast. Cell. Immun. 118, 337-344.
32. ++ population. Develop. Immun, 1, 169-190.
33. King A., Jokhi P. P., Smith S. K., Sharkey A. M. and Loke Y. W. (1995) Screening for cytokine mRNA expression in purified human villous and extravillous trophoblast populations using the reverse-transcriptase polymerase chain reaction (RT-PCR). Cytokine 7, 364-371.
34. King A., Boocock C., Sharkey A. M., Gardner L. and Loke Y. W. (1996) Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J. Immun. 156, 2068-2076.
35. Kovats A., Main E. K., Librach C., Stubblebine M., Fisher S. J. and DeMars R. (1990) A Class I antigen, HLA-G, expressed in human trophoblasts. Science 248, 220-223.
36. Lanier L. L., Gumperz J. E., Parham P., Melero I., López-Botet M. and Phillips J. H. (1995) The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J. Immun. 154, 3320-3327.
37. Lanier L. L. and Phillips J. H. (1996) Inhibitory MHC class I receptors on NK cells and T cells. Immun. Today 17, 86-91.
38. Litwin V., Gumperz J., Parham P., Phillips J. H. and Lanier L. L. (1994) NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. exp. Med. 180, 537-543
39. Loke Y. W. and King A. (1995) Human Implantation: Cell Biology and Immunology, Cambridge University Press, Cambridge, U.K.
40. Loke Y. W., King A., Burrows T., Gardner L., Bowen M., Hiby S., Howlett S., Holmes N. and Jacobs D. (1997) Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. Tissue Antigens. In press.
41. McMaster M. T., Librach C. L., Zhou Y., Lim K.-H., Janatpour M. J., DeMars R., Kovats S., Damsky C. and Fisher S. J. (1995) Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J. Immun. 154, 3771-3778.
42. Manaseki S. and Searle R. F. (1989) Natural killer (NK) cell activity of first trimester human decidua. Cell. Immun. 121, 166-173.
43. Mandelboim O., Davis D. M., Reyburn H. T., Valés-Gómez M., Sheu E. G., Pazmany L. and Strominger J. L. (1996) Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins. Science 274, 2097-2100.
44. Melero I., Salmerón A., Balboa M. A., Aramburu J. and López-Botet M. (1994) Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J. Immun. 152, 1662-1673.
45. - natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. exp. Med. 172, 1589-1598.
46. - natural killer cells. J. exp. Med. 171, 695-714.
47. Moretta A., Vitale M., Bottino C., Orengo A. M., Morelli L., Augugliaro R., Barbaresi M., Ciccone E. and Moretta L. (1993) P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. exp. Med. 178, 597-604.
48. Moretta A., Sivori S., Vitale M., Pende D., Morelli L., Augugliaro R., Bottino C. and Moretta L. (1995) Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. exp. Med. 182, 875-884.
49. + natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua. Int. Immun. 3, 743-750.
50. Olcese L., Lang P., Vely F., Cambiaggi A., Marguet D., Blery M., Hippen K. L., Biassoni R., Moretta A., Moretta L., Cambier J. C. and Vivier E. (1996) Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immun. 156, 4531-4534.
51. Pace D., Morrison L. and Bulmer J. N. (1989) Proliferative activity in endometrial stromal granulocytes throughout the menstrual cycle and early pregnancy. J. clin. Path. 42, 35-39.
52. Pazmany L., Mandelboim O., Valés-Gómez M., Davis D. M., Reyburn H. T. and Strominger J. L. (1996) Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274, 792-795.
53. Phillips J. H., Gumperz J. E., Parham P. and Lanier L. L. (1995) Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268, 403-405.
54. Ravetch J. V. and Perussia B. (1989) Alternative membrane forms of FRIII(CD16) on human natural killer cells and neutrophils. J. exp. Med. 170, 481-497.
55. Sanger F., Nicklen S. and Coulson A. R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. natn. Acad. Sci. U.S.A. 74, 5463-5467.
56. Sharkey A. M., King A., Verma S., Hayes L., Clark D. E., Charnock-Jones D. S., Loke Y. W. and Smith S. K. (1996) Expression and localisation of the receptor for leukemia inhibitory factor in human trophoblast and decidua. Abstract for 13th Rochester Trophoblast Conference, Banff. Placenta 17, A.36.
57. Starkey P. M., Sargent I. L. and Redman C. W. G. (1988) Cell populations in human early pregnancy decidua: characterisation and isolation of large granular lymphocytes by flow cytometry. Immunology 65, 129-134.
58. Verma S., King A. and Loke Y. W. (1997) Expression of Killer cell inhibitory receptors on human uterine natural killer cells. Eur. J. Immunol. 27, 979-983.
59. Vitale M., Sivori S., Pende D., Moretta L. and Moretta A. (1995) Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. Proc. natn. Acad. Sci. U.S.A. 92, 3536-3540.
60. Vitale M., Sivori S., Pende D., Augugliaro R., Di Donato C., Amoroso A., Malnati M., Bottino C., Moretta L. and Moretta A. (1996) Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. Proc. natn. Acad. Sci. U.S.A. 93, 1453-1457.
61. Wagtmann N., Biassoni R., Cantoni C., Verdiani S., Malnati M. S., Vitale M., Bottino C., Moretta L., Moretta A. and Long E. O. (1995a) Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 2, 439-449.
62. Wagtmann N., Rajagopalan S., Winter C. C., Peruzzi M. and Long E. O. (1995b) Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3, 801-809.